State Street’s Capricor Therapeutics CAPR Stock Holding History

State Street’s Portfolio CAPR Stock Details CAPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$81.8M	Buy	3,397,150 +1,215,249	+56%	+$36.8M	﹤0.01%	1594
2026 Q1	$66.3M	Buy	2,181,901 +1,352,380	+163%	+$36M	﹤0.01%	1597
2025 Q4	$23.9M	Buy	829,521 +28,177	+4%	+$368K	﹤0.01%	2155
2025 Q3	$5.78M	Sell	801,344 -665,341	-45%	-$4.9M	﹤0.01%	2943
2025 Q2	$14.6M	Sell	1,466,685 -376,115	-20%	-$3.97M	﹤0.01%	2360
2025 Q1	$17.5M	Sell	1,842,800 -365,568	-17%	-$5.07M	﹤0.01%	2212
2024 Q4	$30.5M	Buy	2,208,368 +1,696,055	+331%	+$29.7M	﹤0.01%	1977
2024 Q3	$7.79M	Buy	512,313 +111,291	+28%	+$550K	﹤0.01%	2747
2024 Q2	$1.91M	Buy	401,022 +284,298	+244%	+$1.59M	﹤0.01%	3331
2024 Q1	$793K	Buy	116,724 +31,500	+37%	+$152K	﹤0.01%	3522
2023 Q4	$417K	Buy	85,224 +300	+0.4%	+$976	﹤0.01%	3687
2023 Q3	$290K	Hold	84,924	–	–	﹤0.01%	3829
2023 Q2	$406K	Hold	84,924	–	–	﹤0.01%	3748
2023 Q1	$358K	Hold	84,924	–	–	﹤0.01%	3860
2022 Q4	$328K	Buy	84,924 +5,700	+7%	+$27.2K	﹤0.01%	3916
2022 Q3	$475K	Hold	79,224	–	–	﹤0.01%	3800
2022 Q2	$276K	Hold	79,224	–	–	﹤0.01%	4068
2022 Q1	$272K	Buy	79,224 +7,476	+10%	+$29.5K	﹤0.01%	4273
2021 Q4	$210K	Hold	71,748	–	–	﹤0.01%	4328
2021 Q3	$288K	Hold	71,748	–	–	﹤0.01%	4218
2021 Q2	$368K	Buy	+71,748	New	+$304K	﹤0.01%	3973

Other funds holding CAPR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

State Street's CAPR Position: Q2 2026 in Review

State Street increased its Capricor Therapeutics (CAPR) stake by 56% in Q2 2026, buying an estimated $36.8M and bringing the position to 3,397,150 shares worth $81.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1594.

State Street first reported a position in CAPR in Q2 2021 and has held it in 21 quarters since. 170 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

State Street held 3,397,150 shares of Capricor Therapeutics worth $81.8M as of Q2 2026.
State Street bought 1,215,249 Capricor Therapeutics shares in Q2 2026, an estimated $36.8M.
Capricor Therapeutics made up ﹤0.01% of State Street's portfolio in Q2 2026, its #1594 holding.
State Street first reported a position in Capricor Therapeutics in Q2 2021 and has held it in 21 quarters since.
170 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.